Vyvanse

Vyvanse Official FDA information, side effects and uses.


Modest launch seen so far for Shire drug Vyvanse



Reuters - LONDON, Aug 23 (Reuters) - Shire Plc's (SHP.L: Quote , Profile , Research ) new hyperactivity drug Vyvanse has had a modest launch so far in the United States, partly reflecting the school holiday period, according to industry analysts. A spokesman ...

Nagging credit concerns rein back early gains
Guardian Unlimited - Prescription data for its key new drug to treat attention deficit hyperactivity disorder (ADHD) - Vyvanse - in the nine weeks since its launch, is "encouraging", according to analysts at Citigroup . They said: "We expect trends to strengthen ...

It's Time To Choose Back-To-School Meds!
Hartford Courant - This month's homemaker-targeted magazines, such as Family Circle, Woman's Day and Redbook, feature advertising spreads for Vyvanse, Shire US Inc.'s new entry in the growing stable of ADHD medications. The ads show "Consistent Kevin through the day ...

Ty's 'Project Playground'
ETOnline.com - The unveiling of "Project Playground" also celebrates the launch of Vyvanse, Shire's newest ADHD treatment for children. "If they do have ADHD, maybe they'll be diagnosed at an early age, because it really affects the rest of your life," says Ty ...

The following is a Sponsored Resource . The sponsor of this content ...
WebMD - Vyvanse has been shown to provide consistent ADHD symptom control for up to 12 hours – from school to homework and family time. In a clinical study with Vyvanse, parents reported that their children's ADHD symptoms were controlled at approximately ...